Increased Cardiovascular Risk Using Atherogenic Index Measurement Among Healthcare Workers

Cuauhtémoc Arturo Juárez-Pérez1, Guadalupe Aguilar-Madrid1, Luis Cuauhtémoc Haro-García2

  • 1Unidad de Investigación de Salud en el Trabajo, Centro Médico Nacional "Siglo XXI", Instituto Mexicano del Seguro Social, Mexico, D.F., México.

Insights

Cardiovascular disease risk factors, including male sex, age, obesity, and high triglycerides, increase the atherogenic index in healthcare workers. Physicians face additional risks due to occupational stress.

Area of Science:

  • Cardiology
  • Occupational Health
  • Public Health

Background:

  • Cardiovascular diseases (CVDs) are a leading global cause of mortality.
  • Healthcare workers experience a disproportionately high burden of CVDs.
  • Identifying risk factors for atherogenic index (AI) is crucial for this population.

Purpose of the Study:

  • To determine the factors contributing to an elevated atherogenic index (AI) among healthcare workers.
  • To analyze cardiovascular risk factors in relation to AI.

Main Methods:

  • A cross-sectional study of 1,678 healthcare workers.
  • Analysis of cardiovascular risk factors: BMI, waist-to-hip ratio, blood pressure, glucose, lipids (TC, HDL, LDL, triglycerides).
  • Calculation of atherogenic index (AI) and identification of determinants using multiple linear regression.

Main Results:

  • High prevalence of overweight and obesity (77.2%).
  • Key determinants of increased AI: male gender, increased age, higher waist-to-hip ratio, elevated triglycerides, and physician occupation.
  • Waist-to-hip ratio was the strongest predictor of AI.

Conclusions:

  • Male sex, age, waist-to-hip ratio, overweight/obesity, and high triglycerides significantly increase AI in healthcare workers.
  • Physicians face elevated AI risk, potentially exacerbated by occupational stress and adverse psychosocial factors.
  • Targeted interventions addressing these determinants are needed to mitigate CVD risk in healthcare professionals.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
783
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
877
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
879
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
605
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
1.1K